News

Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce i3S – Institute of Science and Innovation in Health, based in Porto, Portugal.

To mark World IBD Day 2025, the GENEGUT project is proud to share a special interview featuring voices from across the IBD community. This year’s campaign, “IBD Has No Borders: Breaking Taboos, Talking About It”, launched by EFCCA, GENEGUT’s project partner, shines a spotlight on the ongoing stigma and silence that many people living with IBD still face today.

Our recent review explored the state of the art in smart capsule design, from power supplies and release mechanisms to localisation strategies and future materials. While hurdles remain, ongoing innovation is rapidly bringing this technology closer to real-world application.

While not part of the GENEGUT project itself, a recent publication by researchers from University College Cork (UCC) — a GENEGUT project coordinator — closely aligns with GENEGUT’s mission to explore the role of the gut in chronic disease and innovate therapeutic strategies.

We are excited to announce the second online seminar in the GENEGUT series, this time featuring Dr. Ameya Kirtane from the University of Minnesota as our guest speaker. His talk, titled “Designing solutions for overcoming barriers to gastrointestinal mRNA delivery”, will take place on 5 June 2025 from 4–5 PM CET.

Our GENEGUT partners from EFCCA have launched a new online training initiative: Horizon Europe EFCCA Academy: Diving into the future of IBD Therapies.